Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-01-06FDA Approved: COREG CR — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for COREG CR (carvedilol phosphate) submitted by Waylis Therapeutics LLC.
-
CLINICAL_TRIALS trial_result · 2011-01-06Clinical Trial Update: Efficacy of a Combination of Amlodipine/Valsartan on 24H Blood Pressure Control With One Nocturnal or Diurnal Intake a Day [Phase 4]
A Phase 4 trial evaluated the efficacy of once-daily amlodipine/valsartan for 24-hour blood pressure control, comparing nocturnal versus diu…
-
CLINICAL_TRIALS trial_result · 2011-01-05Clinical Trial Update: Irbesartan and Amlodipine Combination in Controlling Blood Pressure [Phase 2]
Phase 2 trial update evaluates an irbesartan and amlodipine combination for controlling blood pressure in hypertension; the study has comple…
-
CLINICAL_TRIALS trial_result · 2011-01-05Clinical Trial Update: Whole Soy and Daidzein on Reduction of Blood Pressure in Postmenopausal Chinese Women [NA]
This clinical trial investigates whether whole soy and daidzein supplementation reduces blood pressure in postmenopausal Chinese women; curr…
-
FDA approval · 2011-01-04FDA Approved: LOTREL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Lotrel (amlodipine besylate and benazepril hydrochloride) submitted by Novartis Pharmaceutic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-01-04Clinical Trial Update: Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension [Phase 3]
Phase 3 trial results for the fixed-dose combination of telmisartan and amlodipine in severe hypertension have been completed and posted.
-
FDA approval · 2010-12-27FDA Approved: RAMIPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for ramipril from Hikma Pharmaceuticals USA Inc., likely related to labeling or formulation changes …
-
FDA approval · 2010-12-27FDA Approved: FUROSEMIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for furosemide filed by Chartwell RX, LLC, authorizing changes under the supplemental NDA. The appro…
-
CLINICAL_TRIALS trial_result · 2010-12-15Clinical Trial Update: Administration Time-dependent Antihypertensive Effects of Low Dose Aspirin in Well-controlled Hypertensive Patients [Phase 4]
This Phase 4 trial examines whether the timing of low-dose aspirin administration affects antihypertensive effects in patients with well-con…
-
CLINICAL_TRIALS trial_result · 2010-12-15Clinical Trial Update: Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension. [Phase 4]
A Phase 4 study comparing the efficacy and safety of the valsartan/hydrochlorothiazide combination versus valsartan or hydrochlorothiazide m…
-
CLINICAL_TRIALS trial_result · 2010-12-15Clinical Trial Update: LAAS (Losartan Anti-Atherosclerosis Study)(0954-330)(COMPLETED) [Phase 4]
Completed Phase 4 clinical trial evaluating losartan for potential anti-atherosclerotic effects in patients with hypertension. Results were …
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy [Phase 4]
A Phase 4 trial evaluating moderate versus aggressive treatment with valsartan plus amlodipine in hypertension patients uncontrolled on ARB …
-
CLINICAL_TRIALS trial_result · 2010-12-09Clinical Trial Update: Atorvastatin and Sympathetic Activity in Chronic Kidney Disease [Phase 4]
A Phase 4 clinical trial update reports that atorvastatin, studied for its effects on sympathetic activity in adults with stable chronic kid…
-
CLINICAL_TRIALS trial_result · 2010-12-07Clinical Trial Update: Bioequivalence Study in Healthy Subjects [Phase 1]
A Phase 1 bioequivalence study in healthy subjects sponsored by AstraZeneca for hypertension has completed.
-
CLINICAL_TRIALS research · 2010-12-07Clinical Trial Update: To Assess Adherence to the Treatment and Quality of Life in Patients With Hypertension
A completed clinical trial update evaluating adherence to hypertension treatment and quality of life.
-
CLINICAL_TRIALS trial_result · 2010-12-06Clinical Trial Update: The Efficacy of Spironolactone in Patients With Resistant Hypertension [Phase 2]
Phase 2 trial evaluating spironolactone for resistant hypertension was terminated; the update does not provide efficacy results.
-
CLINICAL_TRIALS trial_result · 2010-12-03Clinical Trial Update: Effect of Soymilk Replacement on Anthropometric and Blood Pressure Value [Phase 4]
Phase 4 clinical trial evaluating whether replacing regular dairy with soymilk affects weight, waist circumference, and blood pressure; the …
-
CLINICAL_TRIALS trial_result · 2010-12-03Clinical Trial Update: Analysis of Antihypertensive Treatment Efficacy
This clinical trial update reports on the analysis of antihypertensive treatment efficacy in an AstraZeneca-sponsored study that has been te…
-
CLINICAL_TRIALS trial_result · 2010-12-03Clinical Trial Update: Retrospective Treatment Pattern Survey for the Patient With and Without History of Stroke
A completed retrospective survey by AstraZeneca evaluating treatment patterns in patients with hypertension, comparing those with and withou…
-
CLINICAL_TRIALS trial_result · 2010-12-03Clinical Trial Update: Hypertensive Treatment Pattern Survey for Type II Diabetes Mellitus Patients With Complication and Hypertension
Completed results from a clinical trial survey examining hypertensive treatment patterns in patients with type 2 diabetes mellitus and hyper…
-
CLINICAL_TRIALS trial_result · 2010-12-02Clinical Trial Update: Atacand (Candesartan) Real Life Study
A real-world study of Atacand (candesartan) in hypertension has completed.
-
CLINICAL_TRIALS research · 2010-12-02Clinical Trial Update: Retrospective Survey for Patients With Hypertension and Diabetes Mellitus
A retrospective survey study involving patients with hypertension (and diabetes mellitus) sponsored by AstraZeneca; status is completed.
-
CLINICAL_TRIALS trial_result · 2010-12-01Clinical Trial Update: COmpliance and Efficacy in Mono and Combination Tablet Study ATacand/Atacand Plus
A completed clinical trial evaluated the compliance and efficacy of candesartan as monotherapy and in the Atacand Plus combination tablet fo…
-
CLINICAL_TRIALS trial_result · 2010-12-01Clinical Trial Update: Crestor RUSH (The Efficacy of RosUvaStatin for Korean Dyslipidemia Patients With Hypertension )
This entry reports a completed clinical trial evaluating rosuvastatin-based therapy (RosUvaStatin) for Korean patients with dyslipidemia and…
-
FDA approval · 2010-11-30FDA Approved: ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for Enalapril Maleate and Hydrochlorothiazide from Dr. Reddy's Laboratories, approving a change to a…